Corticosteroid mast cell

HZA106837 was of variable treatment duration (from a minimum of 24 weeks to a maximum of 76 weeks with the majority of patients treated for at least 52 weeks). In HZA106837 patients were randomised to receive either fluticasone furoate/vilanterol 92/22 micrograms [n=1009] or FF 92 micrograms [n=1010] both administered once daily. In HZA106837 the primary endpoint was the time to first severe asthma exacerbation. A severe asthma exacerbation was defined as deterioration of asthma requiring the use of systemic corticosteroids for at least 3 days or an inpatient hospitalization or emergency department visit due to asthma that required systemic corticosteroids. Adjusted mean change from baseline in trough FEV 1 was also evaluated as a secondary endpoint.

Privacy Policy   |   Terms of Use   |   Site Map   |   About Us   |   Ambassadors   |   Blog   |   Medical Research   |   Landmark Articles   |   Contact Us

  1. Asthma Slideshow Pictures
  2. Take the Asthma Quiz!
  3. 10 Worst Cities for Asthma Slideshow Pictures
IN THIS ARTICLE
  • What Is Asthma?
  • What Causes Asthma?
  • What Are the Risks of Asthma?
  • What Are Asthma Medications and Medical Treatments?
  • Corticosteroid Inhalers for Asthma: Use, Side Effects, and Interactions
  • Oral and Intravenous Corticosteroids for Asthma: Use, Side Effects, and Interactions
  • Leukotriene Inhibitors for Asthma: Use, Side Effects, and Interactions
  • Beta-Agonists for Asthma: Use, Side Effects, and Interactions
  • Anticholinergic Inhalers for Asthma: Use, Side Effects, and Interactions
  • Methylxanthines for Asthma: Use, Side Effects, and Interactions
  • Mast Cell Inhibitors for Asthma: Use, Side Effects, and Interactions
  • Monoclonal Antibodies for Asthma: Use, Side Effects, and Interactions
  • Understanding Asthma Medications Topic Guide
Mast Cell Inhibitors for Asthma: Use, Side Effects, and Interactions

Corticosteroid mast cell

corticosteroid mast cell

Media:

corticosteroid mast cellcorticosteroid mast cellcorticosteroid mast cellcorticosteroid mast cellcorticosteroid mast cell